Systemic estrogen administration at subphysiological levels clearly ameliorated obesity and vulvovaginal atrophy in rats but could not normalize compensatory ERα upregulation, suggesting that this approach may be useful in treating a series of postmenopausal symptoms caused by vaginal atrophy. The gene discussed is ESR1; the disease is Obesity.